Alira Health Appoints Annabel de Maria Chief Patient Officer, Leading Global Patient Partnerships

Building the Future of Healthcare on Patient Engagement

News
Published on:
January 19, 2023

FRAMINGHAM, Mass. – January 19, 2023 – Alira Health, a global healthcare advisory, clinical research and technology company, is pleased to announce today the appointment of Annabel de Maria as Chief Patient Officer. In this leadership capacity, she will spearhead the central role of patient engagement across Alira Health’s continuum of healthcare innovation services. Annabel brings an extensive background and noteworthy experience with over twenty years in the healthcare industry, both as an in-house executive and freelance consultant, focusing on the patient-engagement sector. She originally joined Alira Health as Vice President of Patient Engagement in October 2020, and is based out of the firm’s Barcelona, Spain office.

I am honored to bring the voice of the patient, in collaboration with teams across Alira Health, our clients, and our global partnerships, in this central role as Chief Patient Officer.
Annabel de Maria Chief Patient Officer, Alira Health

“At Alira Health, we truly believe that patients should be at the center of everything we do.” said Gabriele Brambilla, CEO and Co-Founder of Alira Health. “I am proud to have Annabel leading in this critically important position as our Chief Patient Officer, in collaboration with all of our teams and services across Alira Health. Her guidance and leadership enables us to partner with patients throughout the whole lifecycle management of a drug or medical device. We work with clinical teams in co-developing clinical trial protocols with patients. We research diseases with patients from around the globe in order to understand the patient journey and apply the insights to trial protocols, regulatory submissions, Health Technology Assessments (HTAs), and commercialization. We help companies set up patient-centric strategies and build patient support programs. Alira Health is focused on co-creating healthcare solutions with patients for our clients. Annabel will play a critical role as we build the future of healthcare on patient engagement.”

“I am honored to bring the voice of the patient, in collaboration with teams across Alira Health, our clients, and our global partnerships, in this central role as Chief Patient Officer,” Annabel de Maria said. “For over twenty-five years, I have focused my professional experience in pharma and MedTech on patient engagement, working to understand the patient journey throughout many important diseases and to implement groundbreaking plans to support and advocate for patients.”

In her earlier role as Vice President of Patient Engagement, Annabel led Alira Health’s Patient Engagement practice, where she helped clients introduce patient-centric activities into their organizations in a meaningful way. The practice is dedicated to helping organizations harness the power of patient insights, using them to make better decisions, impact outcomes, and enhance the patient experience. The practice’s services include the development of patient-centric strategies, a patient knowledge center, advisory boards, and mobilization programs to facilitate true and fruitful interactions that serve stakeholders across the ecosystem and benefit patients.

Annabel assumes her role as Chief Patient Officer effective immediately. Prior to joining Alira Health, Annabel was Head of Corporate Communications at Almirall and Head of Media Relations Europe at Nestlé Purina. As a consultant, her work focused on global strategy for Champix, Lucentis, and Pradaxa. Annabel’s early career included the Spanish launches of Celebrex, Detrusitol, and Xalatan, with later positions at Pfizer, Bayer, and Novartis Spain. In addition to her role at Alira Health, Annabel teaches patient engagement at the University of Bocconi, and she is the patient representative for the EULAR working group on autoinflammatory diseases.

About Alira Health

Alira Health is a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, in partnership with patients, through innovative technologies and expert guidance. From development to medical care, Alira Health complements the expertise of its Pharma, Biotech, and MedTech clients with a full spectrum of services across their entire solutions lifecycle.

Related news

Multimedia May 26, 2023
Webinar on Advancing Patient Engagement in the Medical Device / MedTech Industry
Engaging with patients, including their caregivers and advocates, is crucial during the planning and execution of clinical trials.
Medical Devices MedTech Patient Engagement
News May 22, 2023
Alira Health Joins France Biotech as an Expert Partner
We are pleased to announce that Alira Health has joined France Biotech, an independent association that brings together healthcare innovation entrepreneurs and their expert partners.
Biotech Clinical Trials France Patient Engagement
Multimedia May 17, 2023
Webinar: How to Increase Patient Engagement in Your Clinical Trials
Engaging with patients, including their caregivers and advocates, is crucial during the planning and execution of clinical trials.
Clinical Trials Patient Engagement
Blog May 17, 2023
Introduction to Patient Engagement in MedTech in the U.S.
Check out these key takeaways from our Playbook for Patient Engagement in MedTech in the U.S. and access the playbook download.
MedTech Patient Engagement USA
News April 5, 2023
Alira Health Joins EMIG to Advance Market Access in the UK
We are pleased to announce that Alira Health has joined the Ethical Medicines Industry Group (EMIG), a multi-stakeholder network and trade association that represents the interests(...)
Market Access Patient Centricity UK
News March 27, 2023
Alira Health CEO Gabriele Brambilla Interviewed by Investment Reports
Alira Health CEO Gabriele Brambilla recently shared his thoughts on the importance of patient engagement and the digital tools that will allow patients to better manage their own health data and care.
Digital Health Patient Advocacy
News March 27, 2023
Renee Willmon and MG Registry featured in new Rare Disease Article Series
In the article, “Alira Health and the MGFA Partner to Develop a Myasthenia Gravis Registry,” Renee shares how her professional journey has led her to her current involvement in(...)
Clinical Trials Digital Health Patient Advocacy Rare Disease
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.